1118264

Abraxis Bioscience, LLC — FEI 3006441852

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 19, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Phoenix, AZ (United States)

Citations

IDCFRDescription
126321 CFR 211.68(b)Computer control of master formula records
135821 CFR 211.100(b)SOPs not followed / documented
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified
440221 CFR 211.192Written record of investigation incomplete